Biotechnology company Imperagen announced on Thursday a £5 million ($6.7 million) seed round led by PXN Ventures, with participation from IQ Capital and Northern Gritstone. The…
Allozymes’ clever method for rapidly testing millions of biological-based chemical reactions is proving to be not just a useful service, but the basis of a unique…